Patients undergoing partial knee replacement have a reduced risk for venous thromboembolism and opioid use in months 3 to 12 after surgery.
Lumbar computed tomography-guided corticosteroid infiltration may effectively alleviate pain associated with a number of conditions, including disk herniation, lumbar stenosis, and spondyloarthrosis.
Tanezumab may effectively improve pain and physical function in patients with moderate to severe hip or knee osteoarthritis pain.
A total of seven evidence based interdisciplinary recommendations for management of henoch-schönlein purpura have been formulated.
In the subset of patients with self-reported psoriatic arthritis, guselkumab demonstrated better maintenance of response and higher efficacy compared with secukinumab in the treatment of moderate to severe plaque psoriasis.
Study aimed to determine the frequency of musculoskeletal manifestations in patients treated with Immune checkpoint inhibitors in a combined rheumatology/oncology outpatient clinic.
Results from the first study showed the overall efficacy at week 54 and the safety profile at week 6 of CT-P13 SC were comparable to CT-P13 IV.
The international, multicenter SEMIRA trial demonstrated the usefulness of a new standardized glucocorticoids dose taper scheme in patients with rheumatoid arthritis receiving tocilizumab.
Findings support the interchangeable use of the terms radiographic axial spondyloarthritis and ankylosing spondylitis.
The ORAL Shift study enrolled 694 RA patients who were inadequate responders to methotrexate alone.
A phase 2b study showed that tildrakizumab was significantly more efficacious than placebo in treatment of joint and skin manifestations of psoriatic arthritis by week 24.
Open-label head-to-head trial compared efficacy and safety of ixekizumab with adalimumab in patients with psoriatic arthritis naive to biologic disease-modifying anti-rheumatic drugs.
Investigators examined retrospective data of patients with juvenile idiopathic arthritis and other diseases who received live booster MMR or MMR + varicella while taking disease-modifying antirheumatic drugs, glucocorticosteroids or biological agents.
Study compared efficacy and safety of filgotinib with and without methotrexate in patients with rheumatoid arthritis who were naive to methotrexate therapy.
Investigators sought to determine the efficacy of ultrasound to forecast the development of arthritis among patients with anti-citrullinated protein antibodies with musculoskeletal pain.
MAXIMISE is an ongoing study evaluating the efficacy and safety of secukinumab 300 mg or 150mg in managing axial manifestations in patients with psoriatic arthritis.
As previous studies indicated that all-cause hospitalizations in patients with gout in the United States have overwhelmingly increased by 410% in the last 22 years, researchers sought to determine the potential reasons for the excess hospitalizations.